XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows From Operating Activities:    
Net Loss $ (18,679) $ (32,674)
Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities:    
Depreciation and Amortization 576 668
Stock-based Compensation 315 943
Increase in Inventory Reserves 610 146
Amortization of Right of Use Asset 2,013 1,847
Amortization of Debt Financing Costs and Accretion of Debt Discount 369 369
Loss on Disposal of Assets (3) 8
Realized Loss on Sale of Investments Available-for-Sale (4) 0
Foreign Currency Translation Adjustment (3) 2
Changes in Assets and Liabilities:    
Increase in Accounts Receivable, net (346) (1,742)
Increase in Inventory (2,101) (656)
Decrease in Other Assets 2,720 1,823
(Decrease) Increase in Accounts Payable 314 (416)
Decrease in Lease Liability (1,903) (1,771)
(Decrease) Increase in Other Liabilities 2,534 (48)
Decrease in Deferred License Revenue (3,826) (2,033)
Changes in Assets and Liabilities (2,608) (4,843)
Cash Used In Operating Activities (17,414) (33,534)
Cash Flows From Investing Activities:    
Purchase of Investments Available-for-Sale (21,297) (26,058)
Sale of Investments Available-for-Sale 19,182 26,891
Purchase of Equipment (281) (522)
Cash (Used In) Provided By Investing Activities (2,396) 311
Cash Flows From Financing Activities:    
Payments on Short Term Note Payable (1,443) (1,530)
Payments on Debt (11,750) (750)
Proceeds from issuance of Common Stock for payment related to services provided 0 107
Repurchase of Common Stock to Pay Employee Withholding Taxes 0 (6)
Cash Provided By (Used in) Financing Activities 16,632 (2,179)
Decrease In Cash and Cash Equivalents (3,178) (35,402)
Cash and Cash Equivalents At Beginning Of Period 13,280 48,682
Cash and Cash Equivalents At End Of Period 10,102 13,280
Supplemental Disclosure of Cash Flow Information:    
Cash Paid for Interest 1,470 1,827
Supplemental Disclosure of Noncash Investing Activities:    
Change in Unrealized Loss on Marketable Securities Available-for-Sale 114 (6)
Insurance Financing Note Payable 503 437
Fair Value of Warrants issued related to Debt Financing 501 501
Public offering    
Cash Flows From Financing Activities:    
Proceeds from the Issuance of Common Stock 15,016 0
Offering Costs from the Issuance of Common Stock (106) 0
At -the-market    
Cash Flows From Financing Activities:    
Proceeds from the Issuance of Common Stock 15,000 0
Offering Costs from the Issuance of Common Stock $ (85) $ 0